Clinical Trial

Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques

Study acronym: EItoCVP
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 14, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Effects of inclisiran + statins vs. statins on the morphology and vascular function of coronary vulnerable plaques, in order to provide a better treatment and more detailed imaging basis for the treatment of coronary vulnerable plaques.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-28.
Status change: Not Yet Recruiting → Recruiting 2025-02-12
Trial Details
NCT Number NCT06338293
Lead Sponsor Nanjing First Hospital, Nanjing Medical University
Conditions Coronary Artery Disease
Enrollment 40 participants
Start Date 2024-03-15
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-14